Showing results (81-90 of 111) with videos related to
Sort By:
Pageof 12
Cancer Research|November 3, 2004
SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivoMartin Uhl, Steffen Aulwurm, Jörg Wischhusen, et al.Journal of Neurochemistry|July 1, 2014
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?Dieter Lemke, Markus Weiler, Jonas Blaes, et al.Cell Stem Cell|May 20, 2014
Targeting self-renewal in high-grade brain tumors leads to loss of brain tumor stem cells and prolonged survivalZhe Zhu, Muhammad Amir Khan, Markus Weiler, et al.Nature Plants|July 19, 2016
Recovery of trees from drought depends on belowground sink controlFrank Hagedorn, Jobin Joseph, Martina Peter, et al.Journal of Neurology|June 6, 2020
Chance or challenge, spoilt for choice? New recommendations on diagnostic and therapeutic considerations in hereditary transthyretin amyloidosis with polyneuropathy: the German/Austrian position and review of the literatureMaike F Dohrn, Michaela Auer-Grumbach, Ralf Baron, et al.Neurology|September 27, 2013
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutationWolfgang Wick, Christoph Meisner, Bettina Hentschel, et al.Journal of Cardiac Failure|December 8, 2023
Effect of Eplontersen on Cardiac Structure and Function in Patients With Hereditary Transthyretin AmyloidosisAhmad Masri, Mathew S Maurer, Brian L Claggett, et al.Journal of Neurology|August 14, 2024
Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansformIsabel Conceição, John L Berk, Markus Weiler, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 9, 2026
Guidelines for the management of hereditary ATTR amyloidosis 2026Yoshiki Sekijima, Mitsuharu Ueda, John L Berk, et al.Oncotarget|February 17, 2015
Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastomaTobias Kessler, Felix Sahm, Jonas Blaes, et al.Pageof 12